Cargando…

Cognitive Performance of Patients with Adult 5q-Spinal Muscular Atrophy and with Amyotrophic Lateral Sclerosis

Motor neuron diseases, such as spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS), share several clinical similarities while differing substantially in etiology, disease onset and progression. Cognitive dysfunction, a clinically relevant non-motor feature in a substantial proporti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osmanovic, Alma, Wieselmann, Gary, Mix, Lucas, Siegler, Hannah Alexandra, Kumpe, Mareike, Ranxha, Gresa, Wurster, Claudia D., Steinke, Alexander, Ludolph, Albert C., Kopp, Bruno, Lulé, Dorothée, Petri, Susanne, Schreiber-Katz, Olivia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822456/ https://www.ncbi.nlm.nih.gov/pubmed/33374658 http://dx.doi.org/10.3390/brainsci11010008

Ejemplares similares

Improvement of muscle strength in specific muscular regions in nusinersen-treated adult patients with 5q-spinal muscular atrophy
por: Schreiber-Katz, Olivia, et al.
Publicado: (2023)

An observational cohort study on impact, dimensions and outcome of perceived fatigue in adult 5q-spinal muscular atrophy patients receiving nusinersen treatment
por: Binz, Camilla, et al.
Publicado: (2020)

Executive function is inversely correlated with physical function: the cognitive profile of adult Spinal Muscular Atrophy (SMA)
por: Mix, Lucas, et al.
Publicado: (2021)

Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy
por: Osmanovic, Alma, et al.
Publicado: (2020)

Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
por: Osmanovic, Alma, et al.
Publicado: (2021)

Health-Related Quality of Life in Spinal Muscular Atrophy Patients and Their Caregivers—A Prospective, Cross-Sectional, Multi-Center Analysis
por: Wohnrade, Camilla, et al.
Publicado: (2023)

Nusinersen Wearing-Off in Adult 5q-Spinal Muscular Atrophy Patients
por: Osmanovic, Alma, et al.
Publicado: (2021)

Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophy
por: Binz, Camilla, et al.
Publicado: (2022)

Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
por: Freigang, Maren, et al.
Publicado: (2021)

Cerebrospinal Fluid Parameters in Antisense Oligonucleotide-Treated Adult 5q-Spinal Muscular Atrophy Patients
por: Müschen, Lars Hendrik, et al.
Publicado: (2021)

An observational cohort study on pulmonary function in adult patients with 5q-spinal muscular atrophy under nusinersen therapy
por: Bjelica, Bogdan, et al.
Publicado: (2023)

Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy
por: Freigang, Maren, et al.
Publicado: (2022)

Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatment
por: Freigang, Maren, et al.
Publicado: (2021)

Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany
por: Schönfelder, Erik, et al.
Publicado: (2020)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Heterozygous DHTKD1 Variants in Two European Cohorts of Amyotrophic Lateral Sclerosis Patients
por: Osmanovic, Alma, et al.
Publicado: (2021)

Ethical Principles in Patient-Centered Medical Care to Support Quality of Life in Amyotrophic Lateral Sclerosis
por: Lulé, Dorothée, et al.
Publicado: (2019)

Amyotrophic Lateral Sclerosis and Progressive Muscular Atrophy
por: Williamson, R. T.
Publicado: (1907)

Saccadic intrusions in amyotrophic lateral sclerosis (ALS)
por: Becker, Wolfgang, et al.
Publicado: (2019)

Disease burden of spinal muscular atrophy in Germany
por: Klug, Constanze, et al.
Publicado: (2016)

Quality of Life in SMA Patients Under Treatment With Nusinersen
por: Mix, Lucas, et al.
Publicado: (2021)

Neuropsychological deficits have only limited impact on psychological well-being in amyotrophic lateral sclerosis
por: Schrempf, Till, et al.
Publicado: (2021)

Longitudinal monitoring of amyotrophic lateral sclerosis by diffusion tensor imaging: Power calculations for group studies
por: Behler, Anna, et al.
Publicado: (2022)

A Computational Study of Executive Dysfunction in Amyotrophic Lateral Sclerosis
por: Steinke, Alexander, et al.
Publicado: (2020)

A multivariate Bayesian classification algorithm for cerebral stage prediction by diffusion tensor imaging in amyotrophic lateral sclerosis
por: Behler, Anna, et al.
Publicado: (2022)

Maximum bite force in patients with spinal muscular atrophy during the first year of nusinersen therapy – A pilot study
por: Kruse, Teresa, et al.
Publicado: (2020)

Multimodal in vivo staging in amyotrophic lateral sclerosis using artificial intelligence
por: Behler, Anna, et al.
Publicado: (2022)

Religiosity in patients with amyotrophic lateral sclerosis, a cross-country comparison
por: Ciećwierska, Katarzyna, et al.
Publicado: (2023)

Functional connectivity changes resemble patterns of pTDP-43 pathology in amyotrophic lateral sclerosis
por: Schulthess, Ines, et al.
Publicado: (2016)

Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker
por: Kassubek, Jan, et al.
Publicado: (2018)

Well‐being on supportive techniques in amyotrophic lateral sclerosis: from neurologists' perspective
por: Barć, Krzysztof, et al.
Publicado: (2022)

TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy
por: Turner, Bradley J, et al.
Publicado: (2008)

Differences in F-Wave Characteristics between Spinobulbar Muscular Atrophy and Amyotrophic Lateral Sclerosis
por: Fang, Jia, et al.
Publicado: (2016)

Perception of Emotional Facial Expressions in Amyotrophic Lateral Sclerosis (ALS) at Behavioural and Brain Metabolic Level
por: Aho-Özhan, Helena E. A., et al.
Publicado: (2016)

Patient-Reported Prevalence of Non-motor Symptoms Is Low in Adult Patients Suffering From 5q Spinal Muscular Atrophy
por: Günther, René, et al.
Publicado: (2019)

Informal Caregiving in Amyotrophic Lateral Sclerosis (ALS): A High Caregiver Burden and Drastic Consequences on Caregivers’ Lives
por: Schischlevskij, Pavel, et al.
Publicado: (2021)

Biomarkers in 5q-associated spinal muscular atrophy—a narrative review
por: Lapp, H. S., et al.
Publicado: (2023)

Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen
por: Wurster, Claudia D., et al.
Publicado: (2019)

Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis
por: Tosolini, Andrew P., et al.
Publicado: (2017)

J wave syndromes in patients with spinal and bulbar muscular atrophy
por: Steinmetz, Karoline, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cn4fcmlucvljii5bdpk1sk8fh0